Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 1998

View Archived Issues

COX-2 inhibitors reported by UPSA

Polypeptide-chelating agent complexes reported by Novartis

Native calcitonin mimetics from ZymoGenetics

Anti-GnRH immunogens disclosed by Aphton

QLT PhotoTherapeutics: Q3 1997 highlights

Company Profile: Teva

Structurally distinct vitamin D analogues from Leo

Antiamnesic compounds described by Gedeon Richter

NOS inhibitors prepared at Ono

Antifungal agents prepared at Pola

Abelcet now approved in 18 countries

Enrollment complete in pivotal trial of P829 for lung cancer imaging

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Oral ganciclovir tested for prevention of CMV disease in transplant recipients

Synaptic, Merck & Co. extend BPH research agreement

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

FDA approves first gene-based cancer diagnostic for U.S. market

Clinical pharmacodynamic profile of 5-HT4 agonist

Indian scientists demonstrate protective effect of NAP against stress organ injury in malaria

Lubeluzole improves clinical outcome in stroke patients

Mechanism of TNF-alpha production in tumor tissues by Ono-4007

Nootropic agent evaluated for the treatment of stroke

Anika files for U.S. approval of osteoarthritis Rx

GR-144053 enhances suppression of neointima formation by losartan following vascular injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...